ALGN
Price
$126.13
Change
+$1.25 (+1.00%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
9.15B
32 days until earnings call
CNVVY
Price
$11.91
Change
-$0.66 (-5.25%)
Updated
Sep 25 closing price
Capitalization
5.99B
47 days until earnings call
Interact to see
Advertisement

ALGN vs CNVVY

Header iconALGN vs CNVVY Comparison
Open Charts ALGN vs CNVVYBanner chart's image
Align Technology
Price$126.13
Change+$1.25 (+1.00%)
Volume$11.87K
Capitalization9.15B
ConvaTec Group
Price$11.91
Change-$0.66 (-5.25%)
Volume$23.2K
Capitalization5.99B
ALGN vs CNVVY Comparison Chart in %
Loading...
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNVVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGN vs. CNVVY commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Buy and CNVVY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ALGN: $126.13 vs. CNVVY: $11.91)
Brand notoriety: ALGN: Notable vs. CNVVY: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALGN: 16% vs. CNVVY: 46%
Market capitalization -- ALGN: $9.15B vs. CNVVY: $5.99B
ALGN [@Pharmaceuticals: Other] is valued at $9.15B. CNVVY’s [@Pharmaceuticals: Other] market capitalization is $5.99B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.13B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whileCNVVY’s FA Score has 1 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • CNVVY’s FA Score: 1 green, 4 red.
According to our system of comparison, CNVVY is a better buy in the long-term than ALGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 4 TA indicator(s) are bullish while CNVVY’s TA Score has 5 bullish TA indicator(s).

  • ALGN’s TA Score: 4 bullish, 3 bearish.
  • CNVVY’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, ALGN is a better buy in the short-term than CNVVY.

Price Growth

ALGN (@Pharmaceuticals: Other) experienced а -4.00% price change this week, while CNVVY (@Pharmaceuticals: Other) price change was -5.25% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.23%. For the same industry, the average monthly price growth was -3.27%, and the average quarterly price growth was +8.57%.

Reported Earning Dates

ALGN is expected to report earnings on Oct 29, 2025.

CNVVY is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALGN($9.15B) has a higher market cap than CNVVY($5.99B). CNVVY has higher P/E ratio than ALGN: CNVVY (28.96) vs ALGN (21.32). CNVVY YTD gains are higher at: 6.136 vs. ALGN (-39.508). ALGN has higher annual earnings (EBITDA): 793M vs. CNVVY (567M). ALGN has more cash in the bank: 901M vs. CNVVY (95.7M). ALGN has less debt than CNVVY: ALGN (123M) vs CNVVY (1.34B). ALGN has higher revenues than CNVVY: ALGN (3.97B) vs CNVVY (2.36B).
ALGNCNVVYALGN / CNVVY
Capitalization9.15B5.99B153%
EBITDA793M567M140%
Gain YTD-39.5086.136-644%
P/E Ratio21.3228.9674%
Revenue3.97B2.36B168%
Total Cash901M95.7M941%
Total Debt123M1.34B9%
FUNDAMENTALS RATINGS
ALGN vs CNVVY: Fundamental Ratings
ALGN
CNVVY
OUTLOOK RATING
1..100
5263
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
10064
SMR RATING
1..100
6686
PRICE GROWTH RATING
1..100
6563
P/E GROWTH RATING
1..100
9383
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNVVY's Valuation (22) in the null industry is somewhat better than the same rating for ALGN (73) in the Medical Specialties industry. This means that CNVVY’s stock grew somewhat faster than ALGN’s over the last 12 months.

CNVVY's Profit vs Risk Rating (64) in the null industry is somewhat better than the same rating for ALGN (100) in the Medical Specialties industry. This means that CNVVY’s stock grew somewhat faster than ALGN’s over the last 12 months.

ALGN's SMR Rating (66) in the Medical Specialties industry is in the same range as CNVVY (86) in the null industry. This means that ALGN’s stock grew similarly to CNVVY’s over the last 12 months.

CNVVY's Price Growth Rating (63) in the null industry is in the same range as ALGN (65) in the Medical Specialties industry. This means that CNVVY’s stock grew similarly to ALGN’s over the last 12 months.

CNVVY's P/E Growth Rating (83) in the null industry is in the same range as ALGN (93) in the Medical Specialties industry. This means that CNVVY’s stock grew similarly to ALGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNCNVVY
RSI
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
58%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
45%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
44%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
51%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
55%
Advances
ODDS (%)
Bullish Trend 22 days ago
75%
Bullish Trend 4 days ago
62%
Declines
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
56%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
47%
View a ticker or compare two or three
Interact to see
Advertisement
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNVVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TSLG10.370.75
+7.80%
Leverage Shares 2X Long TSLA Daily ETF
CONY6.490.12
+1.88%
YieldMax COIN Option Income Strategy ETF
SPVM65.540.66
+1.02%
Invesco S&P 500 Value with Momentum ETF
DAPR38.590.04
+0.11%
FT Vest US Equity Dp Bffr ETF Apr
RORO15.80-0.26
-1.65%
ATAC US Rotation ETF

ALGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGN has been loosely correlated with BAX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGN jumps, then BAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGN
1D Price
Change %
ALGN100%
+1.00%
BAX - ALGN
62%
Loosely correlated
+1.13%
JNDOF - ALGN
60%
Loosely correlated
N/A
LUNG - ALGN
54%
Loosely correlated
+1.75%
ITGR - ALGN
44%
Loosely correlated
-0.28%
NVST - ALGN
43%
Loosely correlated
+1.80%
More

CNVVY and

Correlation & Price change

A.I.dvisor tells us that CNVVY and ALGN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNVVY and ALGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNVVY
1D Price
Change %
CNVVY100%
N/A
ALGN - CNVVY
27%
Poorly correlated
+1.00%
SGHT - CNVVY
25%
Poorly correlated
+0.87%
RVTY - CNVVY
24%
Poorly correlated
+1.22%
KIDS - CNVVY
22%
Poorly correlated
+1.39%
CRL - CNVVY
21%
Poorly correlated
+2.04%
More